Filter Results
:
(1,106)
Show Results For
-
All HBS Web
(1,106)
- People (1)
- News (306)
- Research (683)
- Events (5)
- Multimedia (15)
- Faculty Publications (400)
Show Results For
-
All HBS Web
(1,106)
- People (1)
- News (306)
- Research (683)
- Events (5)
- Multimedia (15)
- Faculty Publications (400)
- 15 Aug 2017
- First Look
First Look at New Research and Ideas, August 15, 2017
"reasonableness" review. Second, Delaware courts should apply basic game theory to identify the deterrent effect of match rights and new economy asset lockups. And...
View Details
Keywords:
Sean Silverthorne
- Web
Teaching Cases - Institute For Strategy And Competitiveness
2008, patients seeking a hip or knee replacement in Stockholm County faced wait times of up to two years of sometimes debilitating pain, intermittent missed work and income, and the View Details
- April 2009 (Revised March 2010)
- Background Note
Restructuring Distressed Companies -- Cross-National Comparisons
This note describes briefly bankruptcy regimes and out of court restructuring in 5 countries, the U.S., the U.K., Germany, France and Japan.
View Details
Keywords:
Restructuring;
Insolvency and Bankruptcy;
Cross-Cultural and Cross-Border Issues;
Laws and Statutes
Fruhan, William E. "Restructuring Distressed Companies -- Cross-National Comparisons." Harvard Business School Background Note 209-111, April 2009. (Revised March 2010.)
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses.
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
information and updates through early 2016. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/717504-PDF-ENG Harvard Business School Case 618-025 Adaptive Platform Trials: The Clinical Trial of...
View Details
Keywords:
Sean Silverthorne
- March 2015 (Revised February 2022)
- Supplement
CV Ingenuity (B): Epilogue
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors?
The...
View Details
Keywords:
CV Ingenuity;
CVI;
Drug Eluting Balloon;
DEB;
Drug Eluting Stent;
Angioplasty Balloon;
FoxHollow;
Medical Device;
Medical Device Startup;
Premarket Approval;
PMA;
Lutonix;
Stellarex;
LEVANT;
ILLUMENATE;
Clinical Trials;
Peripheral Arterial Disease;
PAD;
Healthcare Startups;
Covidien;
Health Care and Treatment;
Health Testing and Trials;
Business Startups;
Commercialization;
Strategy;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
United States;
Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (B): Epilogue." Harvard Business School Supplement 315-087, March 2015. (Revised February 2022.)
- 05 Sep 2017
- First Look
First Look at New Research and Ideas, September 5, 2017
forthcoming Journal of Financial Economics The Effects of Media Slant on Firm Behavior By: Baloria, Vishal P., and Jonas Heese Abstract—The media can impose reputational costs on firms because of its important role as an information...
View Details
Keywords:
Sean Silverthorne
- 15 Jul 2014
- Blog Post
Discovering a new organization and state as an intern
festival / charity event / bike ride every single day for the whole summer! I’m thankful that Walmart is helping us get to know the Northwest Arkansas area while we’re there, since they understand that not every MBA student is clamoring to move there full-time without...
View Details
Keywords:
Consumer Products / Retail
- June 1984
- Case
Federal Trade Commission and the Shared Monopoly Case against the Ready-to-Eat Cereal Manufacturers
By: Thomas K. McCraw and Richard S. Tedlow
Keywords:
Business and Government Relations;
Monopoly;
Courts and Trials;
Food and Beverage Industry;
United States
McCraw, Thomas K., and Richard S. Tedlow. "Federal Trade Commission and the Shared Monopoly Case against the Ready-to-Eat Cereal Manufacturers." Harvard Business School Case 384-265, June 1984.
- 2010
- Chapter
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
By: Arthur A. Daemmrich
Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Health Testing and Trials;
Business and Government Relations;
Risk and Uncertainty;
Safety;
Pharmaceutical Industry;
United States
Daemmrich, Arthur A. "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance." Chap. 13 in The Fragmentation of U.S. Health Care: Causes and Solutions, edited by Einer Elhauge, 301–322. Oxford: Oxford University Press, 2010.
- June 2011 (Revised October 2013)
- Case
Gene Patents (A)
By: Richard Hamermesh, David Kiron and Phillip Andrews
In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues...
View Details
Keywords:
Courts and Trials;
Patents;
Genetics;
Judgments;
Science-Based Business;
Biotechnology Industry;
United States
Hamermesh, Richard, David Kiron, and Phillip Andrews. "Gene Patents (A)." Harvard Business School Case 811-089, June 2011. (Revised October 2013.)
- April 2017
- Article
The New Look of Deal Protection
By: Guhan Subramanian and Fernán Restrepo
Deal protection in mergers and acquisitions (M&A) evolves in response to Delaware case law and the business goals of acquirers and targets. We construct a new sample of M&A deals from 2003 to 2015 to identify four such areas of evolution in current transactional...
View Details
Subramanian, Guhan, and Fernán Restrepo. "The New Look of Deal Protection." Stanford Law Review 69, no. 4 (April 2017): 1013–1074.
- 12 Aug 2019
- Working Paper Summaries
Case Histories of Significant Medical Advances
- 2012
- Other Unpublished Work
Lost in the Clouds: The Impact of Copyright Scope on Investment in Cloud Computing Ventures
By: Josh Lerner and Greg Rafert
Our analysis seeks to understand the impact of changes in copyright scope on investment in new firms. We begin by analyzing the investment effects of the Cartoon Network, et al. v. Cablevision decision in the U.S. and court rulings in France and Germany on venture...
View Details
Keywords:
Technological Innovation;
Venture Capital;
Internet and the Web;
Investment;
Business Startups;
Copyright;
France;
Germany;
United States;
European Union
Lerner, Josh, and Greg Rafert. "Lost in the Clouds: The Impact of Copyright Scope on Investment in Cloud Computing Ventures." 2012.
- 20 Feb 2013
- Research & Ideas
Big Deal: Reflections on the Megamerger of American and US Airways
selling assets, generating additional cash for the company and giving it more flexibility to restructure its operations. Under Section 363 of the Bankruptcy Code, assets can be sold by a court order, without...
View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
data and share it globally. The organization also spearheads a clinical network of 16 research centers to conduct early-phase clinical trials faster and more efficiently. By...
View Details
- 20 Nov 2019
- Video
Zia Mody
Zia Mody, founder of AZB & Partners, a leading corporate law firm in
India, describes the changing relationship...
View Details
- 31 Jan 2020
- Video